Asset Details
Do you wish to reserve the book?
Antifungal Activity of N-Arylbenzoquinaldinium Derivatives against a Clinical Strain of M. Canis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Antifungal Activity of N-Arylbenzoquinaldinium Derivatives against a Clinical Strain of M. Canis
Do you wish to request the book?
Antifungal Activity of N-Arylbenzoquinaldinium Derivatives against a Clinical Strain of M. Canis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Antifungal Activity of N-Arylbenzoquinaldinium Derivatives against a Clinical Strain of M. Canis
2023
Overview
Background:
Microsporum canis (Bodin, 1902) is a dermatophyte, which is widely represented in the developing and the developed world alike. Commonly transmitted from domestic animals it is particularly dangerous for immunosuppressed patients due to AIDS, cancer or transplant surgery. Search for new perspective antimycotic derivatives becomes an urgent task in the disease containment. Previously, several quinolinium analogs were screened for their antibacterial activity (E. coli, St. aurous) by our research team. Furthermore, some N-phenylbenzoquinaldinium derivatives have shown antifungal activity against Candida albicans and Candida krusei.
Aims:
In this study, we sought to investigate fungicidal properties of N-arylbenzoquinaldinium derivatives against a clinical strain of Microsporum canis for future medicinal applications.
Materials and Methods:
N-phenyl-[f]-benzoquinaldinium salts were prepared by a variation of the previously described technique and tested against a clinical strain of the fungus of Microsporum canis 114 harvested from pathogenic material of a patient (Perm, Russia, 2014).
Results:
N-phenyl-[f]-benzoquinaldinium tetrafluoroborate has shown antifungal activity par to (or exceeding) that of commercially available medication. Moreover, this benzoquinaldinium analog can be potentially labelled with tritium by our nuclear-chemical method, making it amenable for the sensitive pharmacokinetic studies.
Conclusions:
N-phenyl-[f]-benzoquinaldinium tetrafluoroborate has been shown as a promising compound for the further development of potent antifungal agents as well as radiotracers for further elucidation of biological pathways of antifungal activity.
Publisher
Wolters Kluwer - Medknow,Medknow Publications and Media Pvt. Ltd,Medknow Publications & Media Pvt. Ltd,Wolters Kluwer Medknow Publications
